GLENMARK PHARMACEUTICALS LT INR 1.0 - COM

Historical Portfolio Holders from Q1 2022 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
150 K
Holdings value Q1 2024
$1.72 M
Value change Q1 2024
-$689 K
Grand Portfolio weight change Q1 2024
0%
Number of holders
1
Number of buys Q1 2024
0
Number of sells Q1 2024
-1
Average buys Q1 2024 %
0
Average sells Q1 2024 %
0%
CUSIP
Y2711C144
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 150 K $1.72 M -$689 K $11.48 1
2023 Q4 210 K $2.16 M -$1.96 M $10.26 1
2023 Q3 401 K $4.13 M $0 $10.29 1
2023 Q2 401 K $3.31 M $0 $8.24 1
2023 Q1 401 K $2.27 M $0 $5.66 1
2022 Q4 401 K $2.06 M $0 $5.13 1
2022 Q3 401 K $1.92 M $0 $4.78 1
2022 Q2 401 K $1.97 M +$269 K $4.90 1
2022 Q1 346 K $2.02 M +$2.02 M $5.84 1